Eric James de Bony
Overview
Explore the profile of Eric James de Bony including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
5
Citations
38
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Martinez R, Finocchiaro C, Delhaye L, Gysens F, Anckaert J, Trypsteen W, et al.
Front Immunol
. 2024 Nov;
15:1444886.
PMID: 39497819
Cancer cells effectively evade immune surveillance, not only through the well-known PD-1/PD-L1 pathway but also alternative mechanisms that impair patient response to immune checkpoint inhibitors. We present a novel co-culture...
2.
Ma H, Bizet M, Soares Da Costa C, Murisier F, de Bony E, Wang M, et al.
Mol Cell
. 2023 Dec;
83(23):4239-4254.e10.
PMID: 38065062
A common mRNA modification is 5-methylcytosine (mC), whose role in gene-transcript processing and cancer remains unclear. Here, we identify serine/arginine-rich splicing factor 2 (SRSF2) as a reader of mC and...
3.
Dewaele S, Delhaye L, De Paepe B, de Bony E, De Wilde J, Vanderheyden K, et al.
Oncogene
. 2021 Nov;
41(1):146.
PMID: 34782722
No abstract available.
4.
Dewaele S, Delhaye L, De Paepe B, de Bony E, De Wilde J, Vanderheyden K, et al.
Oncogene
. 2021 Sep;
41(1):15-25.
PMID: 34508176
Long non-coding RNAs (lncRNAs) can exhibit cell-type and cancer-type specific expression profiles, making them highly attractive as therapeutic targets. Pan-cancer RNA sequencing data revealed broad expression of the SAMMSON lncRNA...
5.
de Bony E, Bizet M, Van Grembergen O, Hassabi B, Calonne E, Putmans P, et al.
Oncotarget
. 2018 Jul;
9(45):27605-27629.
PMID: 29963224
Colorectal cancer (CRC) is one of the most common cancers in humans and a leading cause of cancer-related deaths worldwide. As in the case of other cancers, CRC heterogeneity leads...